
Journal Menu
► ▼ Journal Menu-
- Biomolecules Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced

MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.
We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:
- Biology and Life Sciences;
- Chemistry and Materials Sciences;
- Engineering;
- Environmental and Earth Sciences;
- Medicine and Pharmacology;
- Public Health and Healthcare;
- Others.
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
11 September 2024
Meet Us at the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines, 7–9 October 2024, Basel, Switzerland

MDPI will be attending the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ncRNA 2024) in Basel, Switzerland, which will take place from 7 to 9 October 2024. The conference will cover a broad range of topics, from basic biology to medical and technological applications. The sessions will take molecular biology through the topics of disease mechanisms, therapies, technologies, and bioinformatic approaches. Each session will be anchored by leading international speakers.
The following MDPI journals will be represented:
- Biology;
- Biomedicines;
- Biomolecules;
- Cells;
- Epigenomes;
- Genes;
- Life.
If you are attending the conference, please visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://sciforum.net/event/ncRNA2024.
11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced

MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.
We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Chemical Biology”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.
1. “PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds”
by Yeqin Yuan, Huizhi Long, Ziwei Zhou, Yuting Fu and Binyuan Jiang
Biomolecules 2023, 13(1), 93; https://doi.org/10.3390/biom13010093
Full text available online: https://www.mdpi.com/2218-273X/13/1/93
2. “The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker”
by Inês V. da Silva, Sabino Garra, Giuseppe Calamita and Graça Soveral
Biomolecules 2022, 12(7), 897; https://doi.org/10.3390/biom12070897
Full text available online: https://www.mdpi.com/2218-273X/12/7/897
3. “Macrophages in Skin Wounds: Functions and Therapeutic Potential”
by Seen Ling Sim, Snehlata Kumari, Simranpreet Kaur and Kiarash Khosrotehrani
Biomolecules 2022, 12(11), 1659; https://doi.org/10.3390/biom12111659
Full text available online: https://www.mdpi.com/2218-273X/12/11/1659
4. “Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer”
by Jiachao Zhao, Liwei Xu, Di Jin, Yu Xin, Lin Tian, Tan Wang, Daqing Zhao, Zeyu Wang and Jing Wang
Biomolecules 2022, 12(10), 1410; https://doi.org/10.3390/biom12101410
Full text available online: https://www.mdpi.com/2218-273X/12/10/1410
5. “Vitamin D3 Stimulates Proliferation Capacity, Expression of Pluripotency Markers, and Osteogenesis of Human Bone Marrow Mesenchymal Stromal/Stem Cells, Partly through SIRT1 Signaling”
by Ana Borojević, Aleksandra Jauković, Tamara Kukolj, Slavko Mojsilović, Hristina Obradović, Drenka Trivanović, Milena Živanović, Željko Zečević, Marija Simić, Borko Gobeljić et al.
Biomolecules 2022, 12(2), 323; https://doi.org/10.3390/biom12020323
Full text available online: https://www.mdpi.com/2218-273X/12/2/323
6. “Cytochromes P450 of Caenorhabditis elegans: Implication in Biological Functions and Metabolism of Xenobiotics”
by Lucie Larigot, Daniel Mansuy, Ilona Borowski, Xavier Coumoul and Julien Dairou
Biomolecules 2022, 12(3), 342; https://doi.org/10.3390/biom12030342
Full text available online: https://www.mdpi.com/2218-273X/12/3/342
7. “Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders”
by Pradeep Jayarajan Ramakrishna, Anil Shinde, Abdul Rasheed Mohammed, Venkata Ramalingayya Grandhi, Vijay Benade, Vinod Kumar Goyal, Renny Abraham, Venkat Jasti and Jeffrey Cummings
Biomolecules 2023, 13(2), 309; https://doi.org/10.3390/biom13020309
Full text available online: https://www.mdpi.com/2218-273X/13/2/309
8. “The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?”
by Lucas de Freitas Pedrosa, Avraham Raz and João Paulo Fabi
Biomolecules 2022, 12(2), 289; https://doi.org/10.3390/biom12020289
Full text available online: https://www.mdpi.com/2218-273X/12/2/289
9. “Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data”
by Joana S. Vital, Luís Tanoeiro, Ricardo Lopes-Oliveira and Filipa F. Vale
Biomolecules 2022, 12(5), 691; https://doi.org/10.3390/biom12050691
Full text available online: https://www.mdpi.com/2218-273X/12/5/691
10. “Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present”
by Sarah E. Huff, Jordan M. Winter and Chris G. Dealwis
Biomolecules 2022, 12(6), 815; https://doi.org/10.3390/biom12060815
Full text available online: https://www.mdpi.com/2218-273X/12/6/815
10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biology”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.
1. “Molecular Biomarkers in Cancer”
by Virinder Kaur Sarhadi and Gemma Armengol
Biomolecules 2022, 12(8), 1021; https://doi.org/10.3390/biom12081021
Full text available online: https://www.mdpi.com/2218-273X/12/8/1021
2. “Recent Advances in Poly(α-L-glutamic acid)-Based Nanomaterials for Drug Delivery”
by Yu Zhang, Wenliang Song, Yiming Lu, Yixin Xu, Changping Wang, Deng-Guang Yu and Il Kim
Biomolecules 2022, 12(5), 636; https://doi.org/10.3390/biom12050636
Full text available online: https://www.mdpi.com/2218-273X/12/5/636
3. “Melittin-Based Nano-Delivery Systems for Cancer Therapy”
by Anqi Wang, Yuan Zheng, Wanxin Zhu, Liuxin Yang, Yang Yang and Jinliang Peng
Biomolecules 2022, 12(1), 118; https://doi.org/10.3390/biom12010118
Full text available online: https://www.mdpi.com/2218-273X/12/1/118
4. “Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy”
by Liang Hong, Jiangmin Li, Yali Luo, Tao Guo, Chenshuang Zhang, Sha Ou, Yaohang Long and Zuquan Hu
Biomolecules 2022, 12(1), 81; https://doi.org/10.3390/biom12010081
Full text available online: https://www.mdpi.com/2218-273X/12/1/81
5. “Targeting Oxidative Stress Involved in Endometriosis and Its Pain”
by Lauren Clower, Taylor Fleshman, Werner J. Geldenhuys and Nalini Santanam
Biomolecules 2022, 12(8), 1055; https://doi.org/10.3390/biom12081055
Full text available online: https://www.mdpi.com/2218-273X/12/8/1055
6. “Role of Fibroblasts and Myofibroblasts on the Pathogenesis and Treatment of Pelvic Organ Prolapse”
by Zeliha Guler and Jan Paul Roovers
Biomolecules 2022, 12(1), 94; https://doi.org/10.3390/biom12010094
Full text available online: https://www.mdpi.com/2218-273X/12/1/94
7. “Methacrylated Cartilage ECM-Based Hydrogels as Injectables and Bioinks for Cartilage Tissue Engineering”
by Kevin Behan, Alexandre Dufour, Orquidea Garcia and Daniel Kelly
Biomolecules 2022, 12(2), 216; https://doi.org/10.3390/biom12020216
Full text available online: https://www.mdpi.com/2218-273X/12/2/216
8. “Cellulose Nanofiber-Based Aerogels from Wheat Straw: Influence of Surface Load and Lignin Content on Their Properties and Dye Removal Capacity”
by Ramón Morcillo-Martín, Eduardo Espinosa, Laura Rabasco-Vílchez, Laura M. Sanchez,Jorge de Haro and Alejandro Rodríguez
Biomolecules 2022, 12(2), 232; https://doi.org/10.3390/biom12020232
Full text available online: https://www.mdpi.com/2218-273X/12/2/232
9. “Wood Waste from Fruit Trees: Biomolecules and Their Applications in Agri-Food Industry”
by Maria Jose Aliaño-González, Julien Gabaston, Victor Ortiz-Somovilla and Emma Cantos-Villar
Biomolecules 2022, 12(2), 238; https://doi.org/10.3390/biom12020238
Full text available online: https://www.mdpi.com/2218-273X/12/2/238
10. “Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications”
by Longfei Zhu, Xuanyu Zhu and Yan Wu
Biomolecules 2022, 12(4), 580; https://doi.org/10.3390/biom12040580
Full text available online: https://www.mdpi.com/2218-273X/12/4/580
10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Genetics”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.
1. “Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles”
by Yves Menezo, Kay Elder, Arthur Clement and Patrice Clement
Biomolecules 2022, 12(2), 197; https://doi.org/10.3390/biom12020197
Full text available online: https://www.mdpi.com/2218-273X/12/2/197
2. “Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road”
by Rachel E. Lacoursiere, Dania Hadi and Gary S. Shaw
Biomolecules 2022, 12(3), 467; https://doi.org/10.3390/biom12030467
Full text available online: https://www.mdpi.com/2218-273X/12/3/467
3. “Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients”
by Anelis Maria Marin, Sibelle Botogosque Mattar, Rafaela Ferreira Amatuzzi, Roger Chammas, Miyuki Uno, Dalila Luciola Zanette and Mateus Nóbrega Aoki
Biomolecules 2022, 12(6), 769; https://doi.org/10.3390/biom12060769
Full text available online: https://www.mdpi.com/2218-273X/12/6/769
4. “Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues”
by Miriam Longo, Lorenzo Scappaticcio, Paolo Cirillo, Antonietta Maio, Raffaela Carotenuto, Maria Ida Maiorino, Giuseppe Bellastella and Katherine Esposito
Biomolecules 2022, 12(2), 272; https://doi.org/10.3390/biom12020272
Full text available online: https://www.mdpi.com/2218-273X/12/2/272
5. “Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes”
by Cristina Mazzaccara, Raffaella Lombardi, Bruno Mirra, Ferdinando Barretta, Maria Valeria Esposito, Fabiana Uomo, Martina Caiazza, Emanuele Monda, Maria Angela Losi, Giuseppe Limongelli et al.
Biomolecules 2022, 12(10), 1417; https://doi.org/10.3390/biom12101417
Full text available online: https://www.mdpi.com/2218-273X/12/10/1417
6. “Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11”
by Irina Marcovich, Nicholas K. Baer, Olga Shubina-Oleinik, Rachel Eclov, Clayton W. Beard and Jeffrey R. Holt
Biomolecules 2022, 12(7), 914; https://doi.org/10.3390/biom12070914
Full text available online: https://www.mdpi.com/2218-273X/12/7/914
7. “Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench”
by Giovanni Peretto, Elena Sommariva, Chiara Di Resta, Martina Rabino, Andrea Villatore, Davide Lazzeroni, Simone Sala, Giulio Pompilio and Leslie T. Cooper
Biomolecules 2023, 13(4), 646; https://doi.org/10.3390/biom13040646
Full text available online: https://www.mdpi.com/2218-273X/13/4/646
8. “Advances and Challenges in Spatial Transcriptomics for Developmental Biology”
by Kyongho Choe, Unil Pak, Yu Pang, Wanjun Hao and Xiuqin Yang
Biomolecules 2023, 13(1), 156; https://doi.org/10.3390/biom13010156
Full text available online: https://www.mdpi.com/2218-273X/13/1/156
9. “Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes”
by Federica Zatterale, Gregory Alexander Raciti, Immacolata Prevenzano, Alessia Leone, Michele Campitelli, Veronica De Rosa, Francesco Beguinot and Luca Parrillo
Biomolecules 2022, 12(7), 982; https://doi.org/10.3390/biom12070982
Full text available online: https://www.mdpi.com/2218-273X/12/7/982
10. “Grapevine DMR6-1 Is a Candidate Gene for Susceptibility to Downy Mildew”
by Carlotta Pirrello, Giulia Malacarne, Marco Moretto, Luisa Lenzi, Michele Perazzolli, Tieme Zeilmaker, Guido Van den Ackerveken, Stefania Pilati, Claudio Moser and Lisa Giacomelli
Biomolecules 2022, 12(2), 182; https://doi.org/10.3390/biom12020182
Full text available online: https://www.mdpi.com/2218-273X/12/2/182
10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Medicine”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.
1. “NAFLD: Mechanisms, Treatments, and Biomarkers”
by Fatiha Nassir
Biomolecules 2022, 12(6), 824; https://doi.org/10.3390/biom12060824
Full text available online: https://www.mdpi.com/2218-273X/12/6/824
2. “Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges”
by Francisco Rodríguez, Pablo Caruana, Noa De la Fuente, Pía Español, María Gámez, Josep Balart, Elisa Llurba, Ramón Rovira, Raúl Ruiz, Cristina Martín-Lorente et al.
Biomolecules2022, 12(6), 784; https://doi.org/10.3390/biom12060784
Full text available online: https://www.mdpi.com/2218-273X/12/6/784
3. “Biological Effects of Human Exposure to Environmental Cadmium”
by Massimiliano Peana, Alessio Pelucelli, Christos T. Chasapis, Spyros P. Perlepes, Vlasoula Bekiari, Serenella Medici and Maria Antonietta Zoroddu
Biomolecules2023,13(1), 36; https://doi.org/10.3390/biom13010036
Full text available online: https://www.mdpi.com/2218-273X/13/1/36
4. “Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives”
by Daniela Maria Tanase, Evelina Maria Gosav, Madalina Ioana Anton, Mariana Floria, Petronela Nicoleta Seritean Isac, Loredana Liliana Hurjui, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu and Ciprian Rezus
Biomolecules2022, 12(9), 1227; https://doi.org/10.3390/biom12091227
Full text available online: https://www.mdpi.com/2218-273X/12/9/1227
5. “The Role of Tryptophan Dysmetabolism and Quinolinic Acid in Depressive and Neurodegenerative Diseases”
by Knut Hestad, Jan Alexander, Helge Rootwelt and Jan O. Aaseth
Biomolecules2022, 12(7), 998; https://doi.org/10.3390/biom12070998
Full text available online: https://www.mdpi.com/2218-273X/12/7/998
6. “Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy”
by Mohammed Hawash
Biomolecules2022, 12(12), 1843; https://doi.org/10.3390/biom12121843
Full text available online: https://www.mdpi.com/2218-273X/12/12/1843
7. “Cerebral Iron Deposition in Neurodegeneration”
by Petr Dusek, Tim Hofer, Jan Alexander, Per M. Roos and Jan O. Aaseth
Biomolecules2022, 12(5), 714; https://doi.org/10.3390/biom12050714
Full text available online: https://www.mdpi.com/2218-273X/12/5/714
8. “Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation”
by Tatiana A. Fedotcheva, Nadezhda I. Fedotcheva and Nikolai L. Shimanovsky
Biomolecules2022, 12(9), 1299; https://doi.org/10.3390/biom12091299
Full text available online: https://www.mdpi.com/2218-273X/12/9/1299
9. “The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases”
by Yan Wan and Bingkun Zhang
Biomolecules2022, 12(7), 900; https://doi.org/10.3390/biom12070900
Full text available online: https://www.mdpi.com/2218-273X/12/7/900
10. “The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms”
by Jia Liu, Faping Wang and Fengming Luo
Biomolecules2023, 13(1), 119; https://doi.org/10.3390/biom13010119
Full text available online: https://www.mdpi.com/2218-273X/13/1/119
10 September 2024
Meet Us at the 2024 International Conference of the Korean Society for Molecular and Cellular Biology, 8–11 October 2024, Jeju, Republic of Korea

The 2024 International Conference of the Korean Society for Molecular and Cellular Biology will be held from 8 to 11 October 2024, in Jeju, Republic of Korea. The conference is organized by the Korean Society for Molecular and Cellular Biology, and promises a rich tapestry of scholarly exchange across various disciplines within biological and biomedical sciences.
The conference will feature four top keynote speakers in the field of life sciences, including two Nobel Prize winners, and scientists from more than thirty countries around the world participating in more than twenty scientific sessions on a variety of topics. The agenda includes symposiums showcasing pioneering research in life sciences, dedicated sessions for young academics, such as graduate students, postdoctoral researchers, and research professors, and a Bio Job Fair.
The following MDPI journals will be represented at the conference:
- International Journal of Molecular Sciences;
- Antioxidants;
- Biophysica;
- Current Issues in Molecular Biology;
- Kinases and Phosphatases;
- Metabolites;
- Microorganisms;
- Proteomes;
- Bioengineering;
- Biomedicines;
- BioMed;
- Biomolecules;
- Cancers;
- Genes;
- Journal of Molecular Pathology;
- Organoids;
- Plants;
- Non-Coding RNA;
- Sci;
- Journal of Fungi.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #99 and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.ksmcb.or.kr/icksmcb2024/main.html.
3 September 2024
MDPI INSIGHTS: The CEO's Letter #15 - CHORUS, Best Paper Award, August Events

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
I am pleased to share that MDPI is now an Affiliate Member of CHORUS, a not-for-profit organization dedicated to ensuring public access to articles reporting on U.S. government-funded research. This partnership highlights our long-standing commitment to advancing Open Access (OA) publishing and meeting funders’ open research requirements.
Read the full announcement here.
With the White House Office of Science and Technology Policy (OSTP) 2022 memorandum calling for immediate public access to all federally funded research by 2026, this partnership positions MDPI to further support academic institutions in adhering to national mandates while providing authors with fully compliant (CC-BY) OA journals.
The CHORUS platform went live in July 2014 and includes NASA, the U.S. Department of Energy, the U.S. Department of Defense, the U.S. Geological Survey, and the National Science Foundation.
“This partnership positions MDPI to further support academic institutions in adhering to national mandates”
Joining CHORUS perfectly aligns our mission as the leading OA publisher, which is to drive transparency and innovation in scholarly publishing, with that of CHORUS itself, which is to advance Open Access research. It will also support MDPI publications from organizations such as NASA, with 1,200 research papers published by NASA-affiliated authors as at 31 August 2024.
Impactful Research
MDPI’s Best Paper Awards—Award-Winning Papers in 2023 Announced
MDPI is committed to supporting and recognizing the academic community and is proud to announce the recipients of the 2023 Best Paper Awards, which recognize high-quality papers of significant scientific merit and impact. Each year, the editors of our journals carefully select papers that showcase outstanding scientific achievement.
This year, 115 Best Paper Awards were presented, chosen from 346 exceptional papers in a highly competitive selection process. Congratulations to the authors for their remarkable contributions!
To learn more about all the awardees and their research projects, visit the following pages:
- Biology and Life Sciences
- Business and Economics
- Chemistry and Materials Sciences
- Computer Sciences and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Public Health and Healthcare
- Social Sciences, Arts and Humanities
- Physical Sciences
About MDPI Awards
MDPI regularly offers various awards to recognize researchers, particularly young scientists, and to promote communication within the scientific community. These awards exist to inspire and acknowledge talented scientists who have made significant contributions to advancing their fields.
To find out more MDPI awards, please click here.
“Our awards exist to inspire and acknowledge talented scientists”
Inside MDPI
MDPI AI Team Presented at EuroSciPy 2024 in Poland
As part of the CEO Letter, I hold dear this ‘Inside MDPI’ section, where I have an opportunity to highlight various projects, teams and updates within our organization. As such, I’m happy to showcase the following presentations from members of MDPI’s Artificial Intelligence (AI) team, which were recently presented at the EuroSciPy 2024 (16th European Conference on Python in Science). This conference took place in Szczecin, Poland from 26–30 August.
“This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing”
MDPI colleagues Frank Sauerburger (AI Tech Leader) and Daniele Raimondi (Senior Data Scientist) both presented at the conference. Frank discussed MDPI’s AI infrastructure, while Daniele showcased a new methodological approach we have been developing to track the journey of rejected academic manuscripts. This approach combines AI, data science and analytics to improve the identification of manuscripts and authors, enhancing our understanding of publishing dynamics.
This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing. It also allowed us to contribute to the academic discussion on integrating AI and data science into scholarly communication.
From data analysis in Jupyter Notebooks to production applications: AI infrastructure at reasonable scale – Frank Sauerburger
Frank’s presentation on MDPI’s AI infrastructure provided a chance to showcase the advanced technological frameworks that power our operations. Given the technical and academic focus of EuroSciPy, this talk demonstrated how MDPI’s AI capabilities are not only cutting-edge but also central to driving efficiency and innovation in scholarly publishing. Engaging with the EuroSciPy community helps position MDPI as a leader in applying AI within the publishing industry, fostering potential collaborations and attracting interest from top researchers.
A Qdrant and Specter2 framework for tracking resubmissions of rejected manuscripts in academia – Daniele Raimondi
Daniele’s talk on the novel methodological approach that combines AI, Data Science, and Analytics was crucial in highlighting how MDPI is advancing the precision and effectiveness of manuscript and author identification. This approach is pivotal in enhancing our understanding of publishing dynamics and ensuring the quality and integrity of the academic content we manage. By presenting at EuroSciPy, we had the opportunity to engage with an audience deeply involved in scientific computing, gaining feedback and insights that could further refine our methodologies.
Thank you, Frank and Daniele, for representing MDPI so well!
I will share more about MDPI’s AI team and projects in upcoming CEO Letters, as we have a well-rounded AI and Data Team working on an exciting suite of AI products for MDPI and the scholarly community at large.
Coming Together for Science
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
I am pleased to share the success of our MDPI conference The 1st International Conference on Artificial Intelligence (AI) Sensors and the 10th International Symposium on Sensor Science in Singapore this past 1–4 August.
With nearly 400 attendees, the event brought together researchers and industry experts from China, Singapore, Japan, Korea, Taiwan, India and other countries to share their findings on the latest developments in sensors, sensing technology, artificial intelligence for sensing applications and AI-enhanced sensing systems.
We accepted a total of 355 abstracts, featuring 772 authors from 28 countries. Over the course of the four-day event, 66 posters were displayed and 296 talks were delivered, including 4 plenary talks, 46 keynote speeches, 122 invited talks, and 124 selected oral presentations. View the event gallery here.
I am pleased to announce the winners of the four awards, including Best Presentation and Best Poster, recognizing the contributions of our participants during the conference.
Looking ahead, the 2nd International Conference on AI Sensors and Transducers is scheduled to take place from 29 July to 5 August, 2025, in Bangkok, Thailand.
Thank you to our Conference team, including Ionut Spatar, Teodora Nicoleta Cremene, Ang Kai Lin, Benjamin Tay, Leong Jin Yue Esther, Wong Jolin, Judith Wu, Alethea Liu and Flora Li, who were involved in making this event a success. A big thank-you also goes to our local MDPI colleagues for their support: Yu Nwe Soe, Hen Chu Yang, Kwah Zhi En Watcharapong, Zephan Yang, Daphne Neo, Huimin Cheng, Nathan Li and Ting Yin.
Upcoming In-Person Event
25–27 September, 2024
The 5th International Conference on Materials: Advances in Material Innovation
Location: Basel, Switzerland
ICM 2024 will unite experts to share insights on recent advancements in Materials Characterization, Processing and Manufacturing.
7–9 October, 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
The 2nd Sustainable Publishing Forum
In 2022, the International Association of Scientific, Technical and Medical Publishers (STM) outlined three goals to reflect the academic community’s shared aspirations: promoting Open Science, maintaining research integrity and fulfilling social responsibility. Open Science has evolved from the Open Access movement of the early 2000s to become a preferred model in academic publishing. Publishers and academic journals play a crucial role in ensuring research integrity, with efforts to prevent misconduct markedly on the increase now.
As the world faces sustainability challenges, the academic publishing industry is increasingly committed to contributing the achievement of the United Nations Sustainable Development Goals (SDGs). Many publishers are implementing strategies to support these objectives, including ours, which you can view here.
The 2nd MDPI Sustainable Publishing Forum provided a platform for global editors and publishers to discuss these themes, aiming to strengthen collaboration and advance the contributions that scientific publishing can make to academia and society.
“Open Science has evolved to become a preferred model in academic publishing”
The 2nd Sustainable Publishing Forum
We hosted MDPI’s 2nd Sustainable Publishing Forum in Beijing, China, on 15–16 August, attracting nearly 120 attendees from local and international publishers, university presses, scientific and technical journal associations, libraries and the Chinese Academy of Sciences. The event focused on promoting Open Science, maintaining research integrity, and fulfilling social responsibility.
This was an excellent opportunity for us to share more with conference attendees about the approach of our research integrity team. Our Head of Publishing, Peter Roth, also participated, speaking on how to identify and avoid predatory publishers and about the principles that underpin ethical academic publishing.
I extend my thanks to all of our conference speakers, including Hylke Koers (STM Solutions), who presented on STM Trends 2028 and shared insights on the STM Integrity Hub, of which MDPI is a member.
Chief Executive Officer
MDPI AG
19 August 2024
MDPI’s 2023 Young Investigator Awards—Winners Announced

MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.
We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.
MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:
Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.
About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.
To find out more about MDPI awards, please click here.